KinDex Pharmaceuticals's competitors

KinDex Pharmaceuticals's competitors include Vtesse, ADC Therapeutics, Therapeutic Solutions International and Alzheon
Add company...
KinDex Pharmaceuticals
KinDex was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease.
Vtesse
Vtesse's lead compound, VTS-270, has shown promise in pre-clinical and clinical studies as a potential treatment for Niemann-Pick Disease.
ADC Therapeutics
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Therapeutic Solutions International
Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.
Alzheon
Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Founding Date
Founding Date
2009
Founding Date
2014
Founding Date
2010
Founding Date
2007
Founding Date
2013
Type
Type
Private
Type
Private
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Seattle, US HQ
Locations
Gaithersburg, US HQ
Locations
Epalinges, CH HQ
Greater London, GB
San Mateo, US
New Providence, US
Locations
Oceanside, US HQ
Locations
Framingham, US HQ
Employees
Employees
2
Employees
N/A
Employees
623% increase
Employees
7
Employees
11

Funding

Latest funding round
Latest funding round
$ 327.3k (over 1 year ago)
Latest funding round
$ 17m (almost 2 years ago)
Latest funding round
$ 200m (7 months ago)
Latest funding round
N/A
Latest funding round
$ 15.8m (12 months ago)
Total funding raised
Total funding raised
$ 5.8m
Total funding raised
$ 67m
Total funding raised
$ 425m
Total funding raised
N/A
Total funding raised
$ 37.1m
For sources of this data, please see the company profileDownload Excel

View company profiles

Vtesse
HQ
Gaithersburg, US

Vtesse's lead compound, VTS-270, has shown promise in pre-clinical and clinical studies as a potential treatment for Niemann-Pick Disease.

View company
ADC Therapeutics
HQ
Epalinges, CH
Employees
62↑ 3% increase

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

View company
Therapeutic Solutions International
HQ
Oceanside, US
Employees
7

Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.

View company
Alzheon
HQ
Framingham, US
Employees
11

Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.

View company